This site is intended for healthcare professionals

account_circleSign in
Go to /sign-in page

You can view 5 more pages before signing in

Which women should have assessment of bone loss

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • which woman should have a baseline assessment of bone loss
    • patients with early invasive breast cancer should have a baseline dual energy X-ray absorptiometry (DEXA) scan to assess bone mineral density if they:
      • are starting adjuvant aromatase inhibitor treatment
      • have treatment-induced menopause
      • are starting ovarian ablation/suppression therapy
    • do not offer a DEXA scan to patients with early invasive breast cancer who are receiving tamoxifen alone, regardless of pretreatment menopausal status

Reference:

  1. NICE (June 2023).Early and locally advanced breast cancer: diagnosis and management

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page